Enterprise Financial Services Corp (EFSC)’s Acadia Pharmaceuticals ACAD Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-142	Closed	-$4K	–	987
2016 Q1	$4K	Sell	142 -69	-33%	-$1.5K	﹤0.01%	732
2015 Q4	$8K	Sell	211 -64	-23%	-$2.25K	﹤0.01%	606
2015 Q3	$9K	Buy	275 +210	+323%	+$8.74K	0.01%	560
2015 Q2	$3K	Hold	65	–	–	﹤0.01%	809
2015 Q1	$2K	Hold	65	–	–	﹤0.01%	973
2014 Q4	$2K	Buy	+65	New	+$1.84K	﹤0.01%	992
2014 Q2	–	Sell	-87	Closed	-$2K	–	1280
2014 Q1	$2K	Buy	+87	New	+$2.2K	﹤0.01%	1029

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s ACAD Position: Q2 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of Acadia Pharmaceuticals (ACAD) in Q2 2016, closing a stake of 142 shares — an estimated $4K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in ACAD in Q1 2014 and held it in 7 quarters. The position peaked at $9K in Q3 2015. 228 funds tracked by Wall St. Rank hold ACAD as of Q2 2016.

Enterprise Financial Services Corp (EFSC) reported no remaining Acadia Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 142 Acadia Pharmaceuticals shares in Q2 2016, an estimated $4K.
Enterprise Financial Services Corp (EFSC) first reported a position in Acadia Pharmaceuticals in Q1 2014 and held it in 7 quarters.
Enterprise Financial Services Corp (EFSC)'s Acadia Pharmaceuticals position peaked at $9K in Q3 2015.
228 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2016, filed 29 Jul 2016.